Hematology
Gazyva (Obinutuzumab) – Follicular Lymphoma | HongKong DengYue Medicine
ADCETRIS (Brentuximab Vedotin) – CD30-positive lymphoma | HongKong DengYue Medicine
Ascentage (Lisaftoclax) – CLL/SLL | HongKong DengYue Medicine
Xpovio (Selinexor) – MM & DLBCL | HongKong DengYue Medicine
Xospata (Gilteritinib) – AML | HongKong DengYue Medicine
Tibsovo (Ivosidenib) – AML | HongKong DengYue Medicine
DOPTELET (Avatrombopag) – ITP | HongKong DengYue Medicine
Pepaxto (Melphalan Flufenamide) – Myeloma | HongKong DengYue Medicine
Pemazyre (Pemigatinib) – Cholangiocarcinoma | HongKong DengYue Medicine
BENLYSTA (Belimumab) – Lupus Nephritis | HongKong DengYue Medicine
Praxbind (Idarucizumab) – Dabigatran Toxicity | HongKong DengYue Medicine
Ryzneuta (Efbemalenograstim Alfa)- Febrile Neutropenia Prevention
Aiboding (Cladribine) – HCL | HongKong DengYue Medicine
Calquence (Acalabrutinib) – CLL | DengYueMed
Orelabrutinib – Chronic Lymphocytic Leukemia | DengYueMed
Venclexta (Venetoclax) – CLL | DengYueMed
